Park HJ, Kim HJ, Park SH, Lee JS, Kim AY, Kim SW et al (2018) Primary anorectal melanoma: MRI findings and clinicopathologic correlations. Am J Roentgenol 211:W98-108. https://doi.org/10.2214/AJR.17.18807/ASSET/IMAGES/LARGE/08_17_18807_05C_CMYK.JPEG

Article  Google Scholar 

Chen H, Cai Y, Liu Y, He J, Hu Y, Xiao Q et al (2016) Incidence, surgical treatment, and prognosis of anorectal melanoma from 1973 to 2011: a population-based SEER analysis. Medicine 95:e2770. https://doi.org/10.1097/MD.0000000000002770

Article  PubMed  PubMed Central  Google Scholar 

Ng YYR, Tan GHC, Quek RHH, Farid MBHR, Soo KC, Teo MCC (2018) Clinical patterns and management of primary mucosal melanoma: a single centre experience. ANZ J Surg 88:1145–1150. https://doi.org/10.1111/ANS.14373

Article  PubMed  Google Scholar 

James KV, David RA, Douglas WW, Robert MD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes - PubMed. Cancer 85(8):1686

Article  Google Scholar 

Faure M, Rochigneux P, Olive D, Taix S, Brenot-Rossi I, Gilabert M (2018) Hyperprogressive disease in anorectal melanoma treated by PD-1 inhibitors. Front Immunol 9:360913. https://doi.org/10.3389/FIMMU.2018.00797/BIBTEX

Article  Google Scholar 

Kottakota V, Warikoo V, Yadav AK, Salunke A, Jain A, Sharma M et al (2021) Clinical and oncological outcomes of surgery in Anorectal melanoma in Asian population: a 15 year analysis at a tertiary cancer institute. Cancer Treat Res Commun. https://doi.org/10.1016/J.CTARC.2021.100415

Article  PubMed  Google Scholar 

Kobakova I, Stoyanov G, Popov H, Spasova-Nyagulova S, Stefanova N, Stoev L et al (2018) Anorectal melanoma - a histopathological case report and a review of the literature. Folia Med (Plovdiv) 60:641–646. https://doi.org/10.2478/FOLMED-2018-0040

Article  PubMed  Google Scholar 

Fastner S, Hieken TJ, McWilliams RR, Hyngstrom J (2023) Anorectal melanoma. J Surg Oncol 128:635–644. https://doi.org/10.1002/JSO.27381

Article  CAS  PubMed  Google Scholar 

Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C et al (2017) Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer 81:36–44. https://doi.org/10.1016/J.EJCA.2017.05.014

Article  PubMed  Google Scholar 

Siegal B, Cohen D, Jacob ET (1983) Surgical treatment of anorectal melanomas. Am J Surg 146:336–338. https://doi.org/10.1016/0002-9610(83)90410-5

Article  CAS  PubMed  Google Scholar 

Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C (1990) Patterns of failure in anorectal melanoma. a guide to surgical therapy. Arch Surg 125:313–316. https://doi.org/10.1001/ARCHSURG.1990.01410150035007

Article  CAS  PubMed  Google Scholar 

Emile SH, Horesh N, Garoufalia Z, Gefen R, Dourado J, Wexner SD (2024) A national database analysis of the evolution of outcomes of surgery for anal melanoma. J Surg Oncol. https://doi.org/10.1002/JSO.27631

Article  PubMed  Google Scholar 

Smith HG, Bagwan I, Board RE, Capper S, Coupland SE, Glen J et al (2020) Ano-uro-genital mucosal melanoma UK national guidelines. Eur J Cancer 135:22–30. https://doi.org/10.1016/J.EJCA.2020.04.030

Article  PubMed  Google Scholar 

Grant-Freemantle MC, Lane O’Neill B, Clover AJP (2021) The effectiveness of radiotherapy in the treatment of head and neck mucosal melanoma: Systematic review and meta-analysis. Head Neck 43:323–333. https://doi.org/10.1002/HED.26470

Article  PubMed  Google Scholar 

Kakish H, Xu K, Ahmed FA, Loftus AW, Elshami M, Hoehn RS et al (2024) Preoperative therapy in melanoma: evolving perspectives in clinical trials. Crit Rev Oncol Hematol. https://doi.org/10.1016/J.CRITREVONC.2023.104193

Article  PubMed  Google Scholar 

Michielin O, van Akkooi A, Lorigan P, Ascierto PA, Dummer R, Robert C et al (2020) ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol 31:1449–1461. https://doi.org/10.1016/J.ANNONC.2020.07.005

Article  CAS  PubMed  Google Scholar 

Ogata D, Tsutsui K, Namikawa K, Moritani K, Nakama K, Jinnai S et al (2023) Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era. J Cancer Res Clin Oncol 149:749–755. https://doi.org/10.1007/S00432-022-03933-2

Article  CAS  PubMed  Google Scholar 

Bushara O, Tidwell J, Wester JR, Miura J (2023) The current state of neoadjuvant therapy in resectable advanced stage melanoma. Cancers (Basel). https://doi.org/10.3390/CANCERS15133344

Article  PubMed  Google Scholar 

Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13:S31–S34. https://doi.org/10.4103/SJA.SJA_543_18

Article  PubMed  PubMed Central  Google Scholar 

Fields AC, Goldberg J, Senturk J, Saadat LV, Jolissaint J, Shabat G et al (2018) Contemporary surgical management and outcomes for anal melanoma: a national cancer database analysis. Ann Surg Oncol 25:3883–3888. https://doi.org/10.1245/S10434-018-6769-Y

Article  PubMed  Google Scholar 

Wei Pei, Haitao Zhou, Jianan Chen, Qian Liu. Treatment and prognosis analysis of 64 cases with anorectal malignant melanoma. Chinese Journal of Gastrointestinal Surgery 2015:1305–8. https://pubmed.ncbi.nlm.nih.gov/27928805/ Accessed 13 March 2024.

Fadel MG, Mohamed HS, Weir J, Hayes AJ, Larkin J, Smith MJ (2024) Surgical management of primary anorectal melanoma: is less more? J Gastrointest Cancer. https://doi.org/10.1007/S12029-023-01009-Z

Article  PubMed  PubMed Central  Google Scholar 

Brozyna AA, Józwicki W, Roszkowski K, Filipiak J, Slominski AT (2016) Melanin content in melanoma metastases affects the outcome of radiotherapy. Oncotarget 7:17844–17853. https://doi.org/10.18632/ONCOTARGET.7528

Article  PubMed  PubMed Central  Google Scholar 

Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR et al (2023) Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med 388:813–823. https://doi.org/10.1056/NEJMOA2211437/SUPPL_FILE/NEJMOA2211437_DATA-SHARING.PDF

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ong CV, Samlowski W (2024) Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report. Front Oncol. https://doi.org/10.3389/FONC.2024.1301424

Article  PubMed  PubMed Central  Google Scholar 

van Akkooi ACJ, Zijlker LP, Wouters MWJM (2022) Neoadjuvant immune checkpoint inhibitor therapy in melanoma: efficacy. Safety and Timing BioDrugs 36:373–380. https://doi.org/10.1007/S40259-022-00525-X

Article  PubMed  Google Scholar 

Amaria RN, Postow M, Burton EM, Tezlaff MT, Ross MI, Torres-Cabala C et al (2022) Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611:155–160. https://doi.org/10.1038/S41586-022-05368-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A et al (2022) Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol. https://doi.org/10.3389/FONC.2022.1001150

Article  PubMed  PubMed Central  Google Scholar 

Nilsson PJ, Ragnarsson-Olding BK (2009) Importance of clear resection margins in anorectal malignant melanoma. Br J Surg 97:98–103. https://doi.org/10.1002/BJS.6784

Article  Google Scholar